In addition, taken into consideration a potential link between obesity and inflammasomes activation, as well as inverse correlation of serum adiponectin levels and risk of breast cancer, targeting the inflammasome could be a promising strategy for the treatment of breast cancer. This evidence concerns the gene ADIPOQ and breast carcinoma.